Agilon Health (NYSE:AGL) Bolsa

AGILON HEALTH INC

Agilon Health

Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AAMI

ACEL

AXON

CDNA

CLIK

ENVB

FLYW

HCTI

ICCT

LBTYK

LMND

NAMS

PITA

PRCH

SMCI

ZoomInfo sorprende con resultados mejores de lo esperado y sus acciones suben un 19,6%. Descubre qué otras acciones se están moviendo hoy.

Acciones de ZoomInfo se disparan un 20%; 20 acciones que se están moviendo en el premercado de EE.UU.

Agilon Health Inc

T2 Metals Corp

Adventure Gold - United States Dollar

AUSTRAL GOLD LTD ORD by Austral Gold Ltd.

Austral Gold Ltd

ANGELALIGN TECH INC by Angelalign Technologies Inc.

Angelalign Technology Inc

AGL Energy Ltd

AGILITY REAL EST NEW by Agility Real Estate Inc.

Agility Capital Holding Inc

ANGEL TELECOM CORP by Angel Telecom Corp.

AgileThought Inc

ATLANTIS GLORY INC by Atlantis Glory Inc.

Atlantis Glory Inc

HC Wainwright &amp; Co. analyst Edward White reiterates Valneva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VALN#NASDAQ">VALN</a>) with a Buy and maintains $17 price target.

Price Target

Reiteration

Analyst Ratings

VALN

HC Wainwright & Co. Reiterates Buy on Valneva, Maintains $17 Price Target

<a href="https://www.youtube.com/live/tGHr3M7GgpY">https://www.youtube.com/live/tGHr3M7GgpY</a>
&nbsp;

Guidance

Walmart CFO Says 'While The Market Maybe A Little Nervous About Consumer Sentiment At This Very Moment, There Is Nothing That Changes Our View'

Truist Securities analyst Joseph Civello maintains Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) with a Buy and lowers the price target from $380 to $297.

LULU

Truist Securities Maintains Buy on Lululemon Athletica, Lowers Price Target to $297

WIIM

CALM

Cal-Maine Foods shares are trading lower after the company reported worse-than-expected Q3 revenue results. Additionally, the company announced the acquisition of Echo Lake Foods for approximately $258 million and stated it is cooperating with a civil investigative demand by the DOJ into the nationwide increase in egg prices.

Needham analyst David Saxon reiterates Sight Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGHT#NASDAQ">SGHT</a>) from Hold to Hold.

SGHT

Needham Reiterates Hold on Sight Sciencesto Hold

Truist Securities analyst Joon Lee maintains Arvinas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) with a Buy and lowers the price target from $65 to $21.

ARVN

Truist Securities Maintains Buy on Arvinas, Lowers Price Target to $21

At the start of 2025, exposure to the U.S. dollar and American assets like equities and Treasuries was a staple in global investment portfolios, riding high on the back of a resilient economy and a <a href="https://www.benzinga.com/news/econ-s">dominant U.S. exceptionalism narrative. </a>
For years, the global investment narrative leaned heavily on American dominance. Strong tech innovation, high productivity and relatively better demographics helped maintain a performance gap between U.S. equities and their global peers.
That conviction, however, is unraveling just four months later, as escalating trade tensions—spurred by President Donald Trump&#8216;s aggressive tariff push—have dramatically altered the outlook for the world&#8217;s largest economy.
The U.S. dollar and American assets, including both stocks and bonds, are experiencing a broad selloff, raising concerns among investors and challenging assumptions about the stability of U.S. markets.
<h3 class="wp-block-heading">Why Investors Perceive The US Isn't Safe Anymore</h3>
After several days of carnage on Wall Street, investor sentiment remains deeply negative, but the market reaction is beginning to signal something more concerning than just an equity selloff. 
The U.S. Treasury market, traditionally a safe haven during periods of market stress, is no longer playing its usual role.
Yields on the 10-year U.S. Treasury note spiked by 17 basis points during Wednesday's morning session, reaching 4.45%. That move — occurring in tandem with steep equity losses — is counterintuitive. 
Typically, bonds rally and yields fall as investors seek safety when stocks tumble. The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) is now teetering on the brink of a bear market, down nearly 20% from its recent peak, yet Treasuries are offering no refuge.
Instead, bond prices are falling sharply. The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) has declined 3.5% over the last three trading sessions and slid another 3% in premarket trading on Wednesday. 
This marks the worst four-day stretch since 2022, when Treasuries plunged amid the Federal Reserve's rapid-fire rate hikes to combat soaring inflation.
Unlike in 2022, the current bond selloff appears to be driven less by inflation or rate expectations and more by growing concerns about the broader appeal of U.S. assets.
<h3 class="wp-block-heading">Investors Are Liquidating Everything, Even Risk-Free Treasuries</h3>
Worryingly, it suggests that investors are liquidating even high-quality, dollar-denominated holdings to raise cash, as noted by a Citi research report published this week.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Citi on yesterday&#39;s &quot;mysterious rise&quot; in Treasury yields: &quot;This could be an early sign that investors are looking to liquidate positions even in high-quality assets to raise cash.&quot; <a href="https://t.co/8DGVyzq1DG">pic.twitter.com/8DGVyzq1DG</a>
&mdash; Tracy Alloway (@tracyalloway) <a href="https://twitter.com/tracyalloway/status/1909575344908026297?ref_src=twsrc%5Etfw">April 8, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
&#8220;Much of the recent focus has been on the anomalous positive correlation between USD and US stocks,&#8221; Bank of America Global Rates and Currencies team wrote in a note Wednesday. 
"The correlation shifts are consistent with rising U.S. risk premium, ‘peak U.S. exceptionalism,'" said Bank of America. The note advised watching official data and Treasury auctions to assess the changing nature of foreign demand, particularly from unhedged buyers.
"The backdrop of U.S. exceptionalism in recent years has leaned against FX-hedging U.S. equities from a foreign investor perspective," wrote Goldman Sachs analysts. "In a few short months, those conclusions have flipped."
Goldman's FX strategist Michael Cahill said that if tariffs continue to erode corporate margins and reduce real consumer incomes, the central pillar of a strong dollar may crack. The dollar index is already showing signs of strain after months of bullishness.
&#8220;80 days ago in Davos, most common phrase was &#8220;American exceptionalism.&#8221; You heard everywhere. I would say probably every meeting I went to, everyone is focusing on how to do more in the United States. And obviously that&#8217;s been thrown out right now,&#8221; said BlackRock CEO Larry Fink during an event at the Economic Club of New York. 
Jefferies strategist Chris Woods also believes that the U.S. has likely peaked in terms of its share of global stock market capitalization. He sees limited upside for U.S. equities amid high valuations and slowing growth, and said that emerging market equities could begin to outperform if the dollar weakens further.
According to DataTrek Research, the so-called "American exceptionalism trade" relied on a virtuous cycle: rising stock prices drove capital allocation and underpinned economic policy that reinforced financial markets.
This self-sustaining loop has endured for 15 years, but a prolonged bout of volatility could cause lasting damage.
"A few weeks of turmoil does not necessarily threaten it. A few months of ever-lower stock prices, however, risks permanently damaging investors' confidence in its foundations," DataTrek said.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">1/2 The bedrock of the "American exceptionalism" trade over the last 15 years has been the virtuous circle connecting stock prices, the allocation of corporate/societal capital, and the US government's economic policies&#8230;
&mdash; Nick Colas &amp; Jessica Rabe (DataTrek) (@DataTrekMB) <a href="https://twitter.com/DataTrekMB/status/1909333119456387303?ref_src=twsrc%5Etfw">April 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The sharp selloff in U.S. Treasuries is not indicative of systemic trouble, Treasury Secretary Scott Bessent said Wednesday, calling the move a typical market dislocation driven by leveraged investors unwinding positions — not a sign of deeper instability.
While downplaying domestic risks, Bessent did strike a more hawkish tone on China, suggesting that Beijing could provoke broader global instability if it retaliates against tariffs by weakening its currency.
The U.S. imposed a 104% tariff on Chinese imports, with the impact beginning overnight, while Beijing fired back by raising tariffs on American goods to 84%.
Read now: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44708618/china-retaliates-with-massive-84-tariff-hike-on-us-goods-amid-escalating-trade-war">Xi Jinping Hits Back: China Raises Tariffs On US Goods To 84%, Doubling Down On Trade War</a></li>
</ul>
Photo: FOTOGRIN/Shutterstock

Analyst Color

Equities

Government

Regulations

Broad U.S. Equity ETFs

Specialty ETFs

Treasuries

Econ #s

ETFs

iShares Trust Barclays 20+ Year Treasury Bond Fund

Wall Street's 'American Exceptionalism' Trade Falters As Dollar, Stocks, Bonds All Slide

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is struggling to get back above the $80,000 level, which traders have identified as <a href="https://www.benzinga.com/money/bitcoin-price-prediction">a crucial area of resistance.  </a>
What Happened: In an X <a href="https://x.com/EmperorBTC/status/1909617643352735852">post</a> on Tuesday, crypto trader Emperor provided a detailed analysis of Bitcoin stating that it has recently tapped into a high-confluence buy zone at $74,000–$76,000, where he had placed his long orders. 
With a bounce underway, he now marks $80,000–$81,000 as the key level to watch.
Emperor explained that this resistance aligns with previous range lows and the value area low, making it a strong candidate for taking partial profits. He confirmed that he&#8217;s already exited some positions at $80,000 and will consider re-entering if price cleanly breaks above this level.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44697841/raoul-pal-says-crypto-market-nowhere-near-covid-19-peak-fear">Raoul Pal Says Crypto Market Nowhere Near COVID-19 &#8216;Peak Fear&#8217;</a>
Why It Matters: While some market watchers have been linking BTC's decline to the broader stock market slide, crypto trader Astronomer <a href="https://x.com/astronomer_zero/status/1909905408497795559">challenges</a> that narrative with data. 
He analyzed three major drawdowns and their Bitcoin vs. S&amp;P 500 performance ratios:
<ul>
<li>COVID Crash: S&amp;P -35% vs. BTC -65% → Ratio: 1.85</li>
<li>2022 Bear Market: S&amp;P -26% vs. BTC -77% → Ratio: 2.96</li>
<li>Recent Drop: S&amp;P -23% vs. BTC -30% → Ratio: 1.30</li>
</ul>
Astronomer argues that while macro cycles may cause both markets to drop simultaneously, the scale and behaviour differ significantly. He cautions against using equity market moves to predict Bitcoin's path, saying it often adds confusion and clouds clear decision-making.
Read Next:
<ul>
<li><a href="Millionaire%20Crypto%20Trader%20Reacts%20To%20Bitcoin%20Mega-Crash:%20'You%20Have%20Only%20One%20Job%20Here:%20Survive'">Millionaire Crypto Trader Reacts To Bitcoin Mega-Crash: &#8216;You Have Only One Job Here: Survive&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin Stuck Below $80,000: What's Coming Next?

ABBV

REGN

Shares of drug stocks are trading lower after President Trump reportedly indicated he would announce tariffs on pharmaceuticals.

Truist Securities analyst Srikripa Devarakonda maintains Keros Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROS#NASDAQ">KROS</a>) with a Buy and lowers the price target from $43 to $25.

KROS

Truist Securities Maintains Buy on Keros Therapeutics, Lowers Price Target to $25

SGBX

Safe & Green Holdings Acquires Assets And Business Of County Line Industrial

Needham analyst Gerald Pascarelli maintains Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) with a Buy and raises the price target from $40 to $45.

CELH

Needham Maintains Buy on Celsius Holdings, Raises Price Target to $45

Oppenheimer analyst Brian Schwartz maintains Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) with a Outperform and lowers the price target from $135 to $90.

AGYS

Oppenheimer Maintains Outperform on Agilysys, Lowers Price Target to $90

<ul>
<li>TSLA</li>
<li>NVDA</li>
<li>AAPL</li>
<li>COAL</li>
<li>GLD</li>
<li>TLT</li>
<li>MSTR</li>
<li>BABA</li>
<li>QQQ</li>
<li>AMZN</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AAPL

AMZN

BABA

COAL

MSTR

NVDA

TSLA

Top 10 Trending Stocks On WallStreetBets As Of April 9, 2025 (Via Swaggy Stocks)

XXII

22nd Century shares are trading higher after the company announced new agreements from former customers to supply filtered cigar products.

Oppenheimer analyst Brian Bittner maintains Shake Shack (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHAK#NYSE">SHAK</a>) with a Outperform and lowers the price target from $155 to $125.

SHAK

Oppenheimer Maintains Outperform on Shake Shack, Lowers Price Target to $125

<ul>
<li>Kaspersky has warned of brand new smartphones infected with malware.</li>
<li>The malware offers hijackers nearly unlimited control of a user&#8217;s device, including the ability to steal their crypto.</li>
<li>Malware targeting crypto users appears to be on the rise.</li>
</ul>
Hackers are rapidly evolving in their quest to rob everyday people of their wealth, and this is especially true in the cryptocurrency space.
Before, it used to be that you would need to connect your wallet to a malicious website or download a fraudulent application to get your cryptocurrency wallet compromised. Now, a security report suggests that all it might take is a seemingly good deal on a brand-new smartphone.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.55 per share now</a>.</li>
</ul>
<h2 class="wp-block-heading">A Ghost From The Past</h2>
Last week, cybersecurity firm Kaspersky <a href="https://www.kaspersky.ru/about/press-releases/novaya-versiya-triada-kradyot-kriptovalyutu-akkaunty-v-messendzherah-i-podmenyaet-nomera-telefonov-vo-vremya-zvonkov">warned</a> that users are at risk of buying smartphones that are already infected with malware. The firm disclosed that it had discovered modified versions of the so-called Triada Trojan on counterfeit smartphones sold in online shops.
&#8220;An unsuspecting buyer risks purchasing such a gadget, for example, in online stores at reduced prices,&#8221; the firm said.
The Triada Trojan is not new malware. First <a href="https://www.kaspersky.com/blog/triada-trojan/11481/">discovered</a> in 2016, it remains &#8220;one of the most complex and dangerous threats to Android,&#8221; according to Kaspersky cybersecurity analyst Dmitry Kalinin. This view comes as the malware latches on to the root of all system and application processes, making it a part of every app once it launches.&nbsp;
Trending: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
While previous versions hid within the phone&#8217;s RAM, the new version is baked into the device&#8217;s firmware, making detecting it even more challenging.&nbsp;
The malware offers hackers unfettered control of the user&#8217;s device with the ability to steal cryptocurrency by replacing addresses in wallet and exchange applications, hijack social media accounts, intercept calls and messages and more, all with the ability to cover their tracks.
According to Kaspersky, there were at least 2,600 confirmed cases of this malware infection between March 13 and March 27 alone, with about $270,000 in confirmed cryptocurrency thefts.
The security firm speculated that the compromise likely occurred somewhere in the supply chain, with stores likely unaware that they were selling infected devices.
See Also: If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?
<h2 class="wp-block-heading">How To Stay Safe</h2>
As outlined by Kaspersky, there are two main ways users can stay safe from the new Triada Trojan exploit. The first is to stick to authorized stores for their smartphone purchases. The second is to set up security solutions to detect malware immediately after purchase.
The recent Triada Trojan warning comes as new malware threats targeting cryptocurrency users appear to be growing rapidly. Just days before, another security firm, Threat Fabric, <a href="https://www.benzinga.com/content/44555236/new-crocodilus-android-malware-steals-sensitive-crypto-wallet-credentials-research">warned of a new Trojan called Crocodilus</a>. This Trojan used overlays within crypto wallet apps to obtain user seed phrases, typically appearing as a prompt for the user to back them up.
At the same time, on March 18, <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44391187/microsoft-alerts-coinbase-metamask-wallet-users-of-new-malware-threat">Microsoft warned of a remote access Trojan</a> targeting several Google Chrome wallet extensions, including MetaMask, Coinbase Wallet and Trust Wallet.
These warnings come as losses to crypto hacks and scams have already surpassed $2 billion year-to-date, nearly double the amount lost within the same period last year, according to cryptocurrency security outfit <a href="https://hacken.io/insights/q1-2025-security-report/">Hacken</a>.
Read Next:
<ul>
<li>Have $200K saved?<a href="https://www.benzinga.com/money/have-200k-saved-heres-how-to-turn-it-into-lasting-wealth"> Here's how to turn it into lasting wealth</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>

Personal Finance

Users Risk Buying Smartphones Preloaded With Crypto-Stealing Malware: What You Need To Know

Mizuho analyst Mara Goldstein maintains Verastem (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTM#NASDAQ">VSTM</a>) with a Outperform and lowers the price target from $9 to $8.

VSTM

Mizuho Maintains Outperform on Verastem, Lowers Price Target to $8

<a href="https://ec.europa.eu/commission/presscorner/detail/es/statement_25_1025" title="https://ec.europa.eu/commission/presscorner/detail/es/statement_25_1025">https://ec.europa.eu/commission/presscorner/detail/es/statement_25_1025</a>

Macro Economic Events

Global

Economics

EU Member States Have Voted In Favor Of The European Commission's Proposal To Introduce Trade Countermeasures Against The United States

Wells Fargo analyst Timur Braziler downgrades OFG Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OFG#NYSE">OFG</a>) from Overweight to Equal-Weight and lowers the price target from $48 to $42.

Downgrades

Wells Fargo Downgrades OFG Bancorp to Equal-Weight, Lowers Price Target to $42

Press Releases

agilon health to Participate at 2024 Wolfe Research Healthcare Conference

agilon health Reports Third Quarter 2024 Results

agilon health Reports ACO REACH Model Results for 2023 Performance Year

Legal

Agilon Health, Inc, B. Riley Financial, Target Corporation, and Getty Images Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information

agilon health Sets Date to Report Fourth Quarter and Full Year 2024 Financial Results

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of agilon health, inc. (NYSE: AGL) and Encourages Long-Term Investors to Contact the Firm

agilon health to Participate in TD Cowen's 45th Annual Health Care Conference

agilon health Reports Fourth Quarter and Full Year Fiscal 2024 Results

agilon health Sets Date to Report First Quarter 2025 Financial Results

agilon health to Participate in BofA Securities 2025 Health Care Conference

GETY

RILY

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Amedisys

Astrana Health

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

BrightSpring Health Services, Inc. - Common Stock

BrightSpring Health

Chemed

Cigna Group

CorVel

CVS Health

Quest Diagnostics Incorporated Common Stock

Quest Diagnostics

DaVita

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

Comments

Agilon Health

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL